-
Views
-
Cite
Cite
Correction, JNCI: Journal of the National Cancer Institute, Volume 98, Issue 20, 18 October 2006, Page 1442, https://doi.org/10.1093/jnci/djj451
- Share Icon Share
Extract
A news story in the Aug. 16, 2006, issue (“Two Targets, One Drug for New EGFR Inhibitors,” Vol. 98, No. 16, 1102–1103 ) incorrectly stated the targets of the drug ZD6474. The drug is targeted at EGFR, VEGFR, and the RET kinase.
Issue Section:
News
You do not currently have access to this article.